Barr Labs unveils generic prostate drug
-
- January
- 31
Barr Laboratories Inc., the Pomona-based generic-drug unit of Barr Pharmaceuticals Inc., has begun marketing a generic version of Merck & Co.’s Proscar drug, used to treat benign enlargement of the prostate in men. Barr began selling its 5 milligram finasteride tablets in the United States under an agreement with Hungarian drug-giant Gedeon Richter following final Food and Drug Administration approval. Barr’s version will compete in a market that had total annual sales of about $398 million in the year ending November, according to industry data, Barr said.
This entry was posted
on Wednesday, January 31st, 2007 at 6:52 pm by David Schepp.
You can follow any responses to this entry through the RSS 2.0 feed.
Print
| 
Email
